Skip to main navigation Skip to search Skip to main content

A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response

  • The IMAGEN Consortium
  • King's College London
  • MRC Laboratory
  • St George's University Hospitals NHS Foundation Trust
  • Fudan University
  • Imperial College London
  • Barts Health NHS Trust
  • Guy's and St. Thomas' Hospitals NHS Foundation Trust
  • University College London
  • San Raffaele Scientific Institute
  • Università Vita-Salute San Raffaele
  • Technische Universität Darmstadt
  • Max Planck Institute for Intelligent Systems
  • University Medical Centre Hamburg-Eppendorf
  • Cardiff University
  • Kingston University
  • University of Oulu
  • Cambridge Cognition Ltd
  • Universität Heidelberg
  • Trinity College Dublin
  • Sainte-Justine Hospital
  • University of Mannheim
  • Institut National de Recherche en Informatique et en Automatique (INRIA) Parietal
  • University of Vermont
  • University of Nottingham
  • Charité – Universitätsmedizin Berlin
  • Physikalisch-Technische Bundesanstalt
  • McGill University
  • Institut National de la Sante et de la Recherche Medicale (INSERM)
  • DIGITEO Labs
  • Bloorview Research Institute
  • University of Bristol
  • Oulu University Hospital
  • National Institute for Health and Welfare (THL)

Research output: Contribution to journalArticlepeer-review

20   Link opens in a new tab Citations (SciVal)

Abstract

The TTC12-ANKK1-DRD2 gene-cluster has been implicated in adult smoking. Here, we investigated the contribution of individual genes in the TTC12-ANKK1-DRD2 cluster in smoking and their association with smoking-associated reward processing in adolescence. A meta-analysis of TTC12-ANKK1-DRD2 variants and self-reported smoking behaviours was performed in four European adolescent cohorts (N = 14,084). The minor G-allele of rs2236709, mapping TTC12, was associated with self-reported smoking (p = 5.0 × 10−4) and higher plasma cotinine levels (p = 7.0 × 10−5). This risk allele was linked to an increased ventral-striatal blood-oxygen level-dependent (BOLD) response during reward anticipation (n = 1,263) and with higher DRD2 gene expression in the striatum (p = 0.013), but not with TTC12 or ANKK gene expression. These data suggest a role for the TTC12-ANKK1-DRD2 gene-cluster in adolescent smoking behaviours, provide evidence for the involvement of DRD2 in the early stages of addiction and support the notion that genetically-driven inter-individual differences in dopaminergic transmission mediate reward sensitivity and risk to smoking.

Original languageEnglish
Pages (from-to)1103-1114
Number of pages12
JournalEuropean Neuropsychopharmacology
Volume28
Issue number10
Early online date11 Aug 2018
DOIs
Publication statusPublished - 31 Oct 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • fMRI
  • Genetics
  • IMAGEN-ALSPAC-NFBC
  • Meta-analysis
  • Risk taking
  • Smoking

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response'. Together they form a unique fingerprint.

Cite this